- Lab Tests
- Health Corner
RISOFOS 35MG contain Risedronate sodium which belongs to a group of medicine called bisphosphonates which are used to treat bone diseases. It is used to prevent and treat osteoporosis in postmenopausal women, increase bone mass in men with osteoporosis, prevent and treat osteoporosis in men and women that is caused by treatment with steroid medicine such as prednisone, Paget’s disease of bone in men and women.
Osteoporosis is a bone disease that develop when bone mineral density and bone mass decreases, or when the quality or structure of bone changes. This can lead to a decrease in bone strength that can increase the risk of fracture (broken bone). During postmenopausal osteoporosis the bone become weaker, more fragile, and more likely to break after a fall or strain. Paget’s disease is a chronic bone disorder which results in enlarged, deformed bone due to excessive breakdown and formation of bone tissue that can cause bones to weaken and may results in bone pain, arthritis, deformities, or fracture.
RISOFOS 35MG works by slowing bone loss to help maintain strong bone and reduce the risk of broken bone (fracture). This medicine is strictly not recommended for use in children and adolescents under 18 years. Before taking this medicine tell your doctor if you have ever had kidney disease, heart disease, liver problems. Pregnant and breastfeeding women should consult their doctor before taking this medicine.
RISOFOS 35MG works by slowing bone loss to help maintain strong bone and reduce the risk of broken bone (fracture).
Always take RISOFOS 35MG exactly as your doctor has told you. This medicine must be taken before food and try to take at the same time each day. It should be swallowed whole with water. Do not crush or chew the medicine.
Try to rest and relax. You can eat and drink slowly or have smaller and frequent meals. Applying heat pad or covered hot water bottle on your stomach may also help. If still pain persists, speak to your doctor.
RISOFOS 35MG should be used with caution in pregnant women. Consult your doctor before taking.
RISOFOS 35MG should be used with caution in breast feeding women. Consult your doctor before taking.
Consumption of alcohol is not recommended during treatment with RISOFOS 35MG.
RISOFOS 35MG is not recommended in patients with active kidney diseases. Before taking this medicine, consult your doctor for advice.
Do not take RISOFOS 35MG if you are allergic (hypersensitive) to risedronate sodium or any other ingredients in this medicine.
Tell your doctor if you have or had a condition such as,
Tell your doctor about all the medicines you use, including prescription and non-prescription medicines and herbal supplements.
|Pharmacological Category||:||Bisphosphonate Derivative|
|Therapeutic Indication||:||Osteoporosis, Paget’s disease of bone|
Store below 20-25°C and keep out of reach of children.
How do you take RISOFOS 35MG?
This medicine must be taken before food. Try to take RISOFOS 35MG at the same time each day. It should be swallowed whole with water. Do not crush or chew the medicine.
Can I take RISOFOS 35MG during pregnancy?
It is not known if risedronate sodium will harm your unborn baby. RISOFOS 35MG should be used with caution in pregnant women. Consult your doctor before taking.
Can I take RISOFOS 35MG during kidney disease?
No, it is not recommended in patients with active kidney diseases. Before taking this medicine, consult your doctor for advice.
1. KD Tripathi. Drugs Affecting Calcium Balance. Essentials of Medical Pharmacology. Seventh Edition,2013. Page - 345.
2. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 3415-3417.
3. P Geusens 1, M McClung. Review of risedronate in the treatment of osteoporosis. NIH: National Library of Medicine, National center of biotechnology Information Pubmed.gov. Dec 2001. [Accessed 18 Dec 2020] https://pubmed.ncbi.nlm.nih.gov/11825332/
4. Procter & Gamble Pharmaceuticals, Inc,1998; U.S. Food & Drug Administration; [Revised on Jul 2009] [Accessed 18 Dec 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020835s035lbl.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.